Peterson AC - Search Results

1

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.

Peterson AC, Harlin H, Karrison T, Vogelzang NJ, Knost JA, Kugler JW, Lester E, Vokes E, Gajewski TF, Stadler WM; University of Chicago Phase II Consortium. Peterson AC, et al. Invest New Drugs. 2006 Mar;24(2):141-9. doi: 10.1007/s10637-006-5935-4. Invest New Drugs. 2006. PMID: 16514482 Clinical Trial.

2

Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.

Peterson AC, Harlin H, Gajewski TF. Peterson AC, et al. J Clin Oncol. 2003 Jun 15;21(12):2342-8. doi: 10.1200/JCO.2003.12.144. J Clin Oncol. 2003. PMID: 12805336 Clinical Trial.

3

Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma.

Peterson AC, Swiger S, Stadler WM, Medved M, Karczmar G, Gajewski TF. Peterson AC, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4048-54. doi: 10.1158/1078-0432.CCR-03-0766. Clin Cancer Res. 2004. PMID: 15217937 Clinical Trial.

4

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.

Harlin H, Kuna TV, Peterson AC, Meng Y, Gajewski TF. Harlin H, et al. Among authors: peterson ac. Cancer Immunol Immunother. 2006 Oct;55(10):1185-97. doi: 10.1007/s00262-005-0118-2. Epub 2006 Feb 9. Cancer Immunol Immunother. 2006. PMID: 16468035 Free PMC article.

5

The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.

Knight D, Peterson AC, Rini BI, Harlin H, Gajewski TF, Stadler WM. Knight D, et al. Among authors: peterson ac. Prostate. 2009 Feb 1;69(2):142-8. doi: 10.1002/pros.20864. Prostate. 2009. PMID: 18942640

6

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells.

Blank C, Brown I, Peterson AC, Spiotto M, Iwai Y, Honjo T, Gajewski TF. Blank C, et al. Among authors: peterson ac. Cancer Res. 2004 Feb 1;64(3):1140-5. doi: 10.1158/0008-5472.can-03-3259. Cancer Res. 2004. PMID: 14871849

7

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski TF. Harlin H, et al. Among authors: peterson ac. Cancer Res. 2009 Apr 1;69(7):3077-85. doi: 10.1158/0008-5472.CAN-08-2281. Epub 2009 Mar 17. Cancer Res. 2009. PMID: 19293190 Free PMC article.

8

T cell development and function in CrkL-deficient mice.

Peterson AC, Marks RE, Fields PE, Imamoto A, Gajewski TF. Peterson AC, et al. Eur J Immunol. 2003 Oct;33(10):2687-95. doi: 10.1002/eji.200324294. Eur J Immunol. 2003. PMID: 14515252 Free article.

9

T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha.

Zha Y, Marks R, Ho AW, Peterson AC, Janardhan S, Brown I, Praveen K, Stang S, Stone JC, Gajewski TF. Zha Y, et al. Among authors: peterson ac. Nat Immunol. 2006 Nov;7(11):1166-73. doi: 10.1038/ni1394. Epub 2006 Oct 8. Nat Immunol. 2006. PMID: 17028589

10

Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer.

Morris MJ, Rathkopf DE, Novotny W, Gibbons JA, Peterson AC, Khondker Z, Ouatas T, Scher HI, Fleming MT. Morris MJ, et al. Among authors: peterson ac. Clin Cancer Res. 2016 Aug 1;22(15):3774-81. doi: 10.1158/1078-0432.CCR-15-2638. Epub 2016 Feb 8. Clin Cancer Res. 2016. PMID: 26858312 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters